Guizhou Yibai Pharmaceutical Co Ltd (600594) — Capital Reinvestment Ratio
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥33.28 Million) in capital expenditures (CN¥7.08 Million). See 600594 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Yibai Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Guizhou Yibai Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see market cap of Guizhou Yibai Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | CN¥256.71 Million | CN¥34.99 Million | ▼ -87.7% |
| 2024 | 1.11x | CN¥86.87 Million | CN¥96.32 Million | ▲ +221.1% |
| 2023 | 0.35x | CN¥377.61 Million | CN¥130.38 Million | ▼ -63.1% |
| 2022 | 0.94x | CN¥345.30 Million | CN¥322.92 Million | ▲ +95.1% |
| 2021 | 0.48x | CN¥934.21 Million | CN¥447.78 Million | ▼ -55.6% |
| 2020 | 1.08x | CN¥366.66 Million | CN¥395.74 Million | ▲ +94.5% |
| 2019 | 0.55x | CN¥362.71 Million | CN¥201.28 Million | ▼ -63.0% |
| 2018 | 1.50x | CN¥214.30 Million | CN¥321.33 Million | ▲ +153.8% |
| 2017 | 0.59x | CN¥681.78 Million | CN¥402.80 Million | ▼ -32.4% |
| 2016 | 0.87x | CN¥380.62 Million | CN¥332.53 Million | ▲ +74.0% |
| 2015 | 0.50x | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥73.46 Million | CN¥22.49 Million | — |